Anne Schoendorf is a prominent inventor based in Bossey, France. She has made significant contributions to the field of biochemistry, particularly in the development of enzymes related to the production of paclitaxel, a vital anti-cancer drug. With a total of 6 patents to her name, her work has had a profound impact on both scientific research and pharmaceutical applications.

Latest Patents

Among her latest patents are two notable inventions. The first patent focuses on "Taxoid oxygenases and their uses," which discloses oxygenase enzymes and their application in producing paclitaxel and related taxoids. This patent also includes nucleic acid sequences encoding these oxygenase enzymes. The second patent, titled "Transacylases of the paclitaxel biosynthetic pathway," details transacylase enzymes and their use in producing paclitaxel and its intermediates. Similar to the first, this patent also discloses nucleic acid sequences encoding the transacylase enzymes.

Career Highlights

Anne Schoendorf is affiliated with Washington State University, where she continues her research and innovation in biochemistry. Her work has not only advanced the understanding of paclitaxel biosynthesis but has also opened new avenues for therapeutic applications in cancer treatment.

Collaborations

Throughout her career, Anne has collaborated with esteemed colleagues such as Rodney Bruce Croteau and Kevin D Walker. These partnerships have enriched her research and contributed to the successful development of her patented technologies.

Conclusion

Anne Schoendorf's contributions to the field of biochemistry, particularly in the area of paclitaxel production, highlight her innovative spirit and dedication to scientific advancement. Her patents and collaborations reflect her commitment to improving cancer treatment through enzyme technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com